December 3, 2013
3-4 PM in Mainz, Germany
TRON – Building 708 at University Medical Center Mainz
Prof. Dr. med. Gunther Hartmann
University Medical Center Bonn, Germany
“RIG-I ligand therapies”
Clinical pharmacologist Hartmann has critically improved the understanding of nucleic acid detection by the immune system, especially with his research into the effect of CpG oligonucleotides on the highly important dendritic cells, and into short-interfering RNAs. These investigations are important for understanding the defense against viruses and the development of a rapid immune response against invading pathogens. Hartmann’s findings can also be used for the development of new vaccines and pharmacologically active substances for the inhibition of genes. The foundation for Gunther Hartmann’s work, which has already been recognized with several national and international awards, was laid with a DFG-funded postdoctoral fellowship in Iowa, United States. From there, Hartmann moved on to Munich and then to Bonn, where he has led the Institute of Clinical Chemistry and Pharmacology since 2007.
For further information about Prof. Hartmann, please see: http://www.meb.uni-bonn.de/klinpharm/index.php?page=ag-hartmann-schlee